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2
Problem

Early/precocious puberty, while a relatively rare condition, occurs in approximately 20
per 10,000 girls. Girls outnumber boys in precocious puberty by a three to one ratio (Steelman,
2011). Approximately 4-5% of girls will go through precocious puberty (Shapiro, 2013).
Early/precocious puberty can present with either signs of adrenarche (increased hormones in the
body), thelarche (breast development, most common first sign), pubarche (appearance of pubic
hair), or menarche (menstruation). With early pubertal timing girls have an increased risk of
being treated differently by adults, with expectations to behave at the age of their outward
appearance instead of their chronological age. Early pubertal timing increases the female’s risk
of sexual abuse, obesity, cardiovascular disease, short adult stature, behavioral problems, breast
cancer due to longer estrogen exposure over their lifetime, and risk taking behaviors such as
alcohol and drug abuse as well as teen pregnancy.
The ages to define the onset of puberty, precocious puberty, and early puberty are
debatable within the medical community. The average age of puberty in girls is 10 to 14 years
old (MedLinePlus, 2013). Precocious puberty is defined as the onset of secondary sexual
characteristics before age 7/8 years in Caucasian girls and 6 years old in African American girls
(Mayo Clinic, 2013). Additionally, menarche before 9 years old is indicative of precocious
puberty (Mercola, 2012). Early puberty would be characterized as secondary sexual
characteristics between 8 and 10 years old, although some define early puberty as less than 12
years for research purposes. It is more commonly found in girls, with African American girls
maturing on average one year earlier than their Caucasian/Hispanic counterparts.
The pituitary gland, which regulates hormonal production and ovarian stimulation, starts
producing hormones early leading to the development of secondary sexual characteristics
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(University of Michigan Health System, 2013). For girls, the increase in estrogen levels
stimulates breast enlargement (Tanner stage 2) in girls and is usually the first sign of puberty.
However, in some cases menarche (menses) or pubarche (pubic hair) can appear first.
Additionally, there is an increase in skeletal maturation, leading to an initial early height
increase. However, final height in early/precocious puberty girls is usually less than their ontime/late puberty counterparts (Shapiro, 2013).
Precocious puberty can be divided into the following: central precocious puberty, or
gonadotropin dependent (usually idiopathic) and peripheral precocious puberty, or gonadotropin
independent (caused by increased estrogen in the body). GnRH testing can help distinguish
between the two. Central precocious puberty, or idiopathic precocious puberty, is the most
common. It is caused by early maturation of the Hypothalamus-Pituitary-Gonadal (HPG) axis.
For central-type puberty to occur, there must be a functioning GnRH neuronal network and
pulsatile GnRH secretions, caused by tonic inhibitory restraints (GABA receptors) and excitatory
inputs (amino acid glutamate) to the GnRH neurons. The GnRH secretion mechanisms are
located within the neuronal and glial networks (Partsch & Sippell, 2001). With HPG, the
hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the anterior
pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These
hormones cause the ovaries to produce estrogen, which influences the development of secondary
sexual characteristics. Although there is usually no identifiable cause in 69% to 98% of girls with
central precocious puberty it may be caused by the following: tumor in the brain/spinal cord,
defect at birth such as hydrocephalus or hamartoma (noncancerous tumor), radiation or injury to
the spinal cord, McCune-Albright syndrome, congenital adrenal hyperplasia, or hypothyroidism
(Mayo Clinic, 2013).
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Peripheral precocious pubertal development is due to premature excretion of sex steroids
from the ovaries, adrenal glands, pituitary, or exogenous exposure. This type of pubertal
development originates peripherally, not centrally at the GnRH pulse generator, and will have
low responses to GnRH stimulation (Partsch & Sippell, 2001). Additionally, the following may
lead to precocious puberty: estrogen-secreting tumor of the adrenal glands or pituitary gland,
McCune-Albright syndrome, and exposure to external sources of estrogen such as
lotions/creams/ointments (Mayo Clinic, 2013).
Possible causes of early or precocious puberty can include problems with the adrenal
gland or ovaries. While there is debate among the medical community on when to test and treat
for early/precocious puberty, providers must contemplate ruling out possible causes for early
pubertal onset by evaluating for tumors and endocrine disorders (diabetes, polycystic ovarian
syndrome, etc.). Obesity, environmental hazards, and social factors can increase the risk of early
puberty (University of Michigan Health System, 2013). This article will review the literature for
early and precocious (both central and peripheral) pubertal onset in girls less than 12 years old to
achieve a better understanding of potential causes, patient impact, and management options.
The Transactional Model of Stress and Coping, by Lazarus and Folkman (1984), views
stress as an interaction between people and their external environment. It interprets stress as a
stressor only if the person perceives it as such. However, if perceived as harmless, or even a
challenge, then the stress is not viewed as a stressor and may even be viewed as a positive.
Additionally, the coping resources the person utilizes can diminish their perception of stress as a
stressor. With adequate coping skills, people can change their viewpoints of stressors and
actually thrive on life’s challenges.
The Transactional Model of Stress and Coping will be examined for girls diagnosed with
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early/precocious puberty. This model looks at the diagnosis (early/precocious puberty), the
appraisal of the situation (personality factors, social support, coping skills) that interacts with
stressors (immunologic/neuroendocrine function), which determine the health outcomes. Within
this study, the diagnosis is early/precocious puberty. The appraisal of the situation involves the
child’s social support network (friends/family), their personality factors (are they anxious
children regularly) and their coping skills (how well are they able to cope with breast
development, pubic hair growth, physician appointments, treatments, etc.). These factors interact
with the endocrinology/pathophysiology of their condition (hyperinsulinemia, hypothyroidism,
etc.) to produce a positive health outcome (healthy status, treatment decisions, mood,
anxiety/depression/etc.). The goal for the early/precocious puberty child would be having a
supportive system, an adaptive personality, and well developed coping skills to achieve a healthy
outcome in regards to decision making, mood, and optimal health status (Lazarus & Folkman,
1984).
Literature Review
Research databases Cinhal, PubMed, Sage Premier, as well online journals (Pediatrics)
and the American Academy of Pediatrics were searched for journal articles published within the
last 15 years. Search terms included early puberty, precocious puberty, early menarche, sexual
maturation, and secondary sex characteristics. The search included articles that contained the
proposed cause of early/precocious puberty, its impact on girls, and the recommended treatment
options.
Causes of Early/Precocious Puberty
Stress. Frigon & Trembaly (2005) examined the stress levels of young girls, their family
life, and the onset of puberty in relation to behavioral outcomes. They found that the girls who
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reported more anxiety at 8 years old had an increased risk of early menses (P=0.01).
Consequently, the girls who entered puberty earlier than their peers reported less sleep
(P=0.002), more externalized problem behaviors (P=0.02), and increased difficulty relating to
their parents and peers (P=0.01).
Abuse. Wise, Palmer, Rothman, & Rosenberg (2009) conducted a retrospective of study
black women that examined childhood physical/sexual abuse and age of menarche. After
adjusted analyses, they found that participants who reported sexual abuse in childhood also
reported earlier menarche. Physical abuse had a weak but still statistically significant link with
early menarche. Women who reported any childhood abuse were 1.12 times more likely to report
early menarche compared to those women who reported no abuse in childhood (95%CI=1.08,
1.16). Physical abuse only victims were 1.05 times more likely to report early menarche
(95%CI=1.01, 1.09). Sexual abuse only victims were 1.27 times more likely (95%CI=1.20, 1.35)
and physical and sexual abuse victims were 1.22 more likely (95%CI=1.16, 1.28) to report early
menarche. Additionally, the more childhood incidences of abuse reported further increased the
risk of early menarche: number of sexual abuse incidents of one to three (1.26, 95%CI=1.18,
1.34) and four or more (1.34, 95%CI=1.23, 1.45).
Obesity. Davison, Susman, & Birch (2003) conducted a longitudinal study of 183 white
girls ranging from 5 to 9 years old to determine if a causal relationship existed between weight
status and pubertal timing. Their results indicated that girls at 5 years of age who had a higher
percent body fat (p<0.01), and girls who were 7 years old with either a higher percent body fat, a
higher BMI, or a larger waist circumference were more at risk of undergoing earlier sexual
development at 9 years old (p<0.001). Approximately 59% of overweight girls at 9 years old
showed early pubertal development. Additionally, girls with earlier puberty exhibited higher
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estradiol levels. This study may indicate that weight status precedes puberty.
Boynton-Jarrett et al. (2011) studied 32,218 mother-daughter dyads, looking at the
correlation between gestational weight gain (GWG) and daughter’s age at menarche. They
showed that mothers who reported a GWG of <10 lbs. or >40 lbs. were 30% more likely to have
daughters with early onset menarche based on adjusted logistic regression models (P=0.0059).
Additionally, GWG by the mother could influence the fetus’ metabolism resulting in increased
risk of childhood obesity and hyperinsulinemia, which might affect pubertal onset.
Anderson, Dallal, & Must (2003) compared data from two national surveys conducted 25
years apart to examine the possible relationship between weight and race’s possible impact on
the average age of menarche. They found that the average age of menarche dropped by
approximately 2 ½ months, from 12.75 to 12.54 years, and the percentage of girls aged 10 to 15
years old whose BMI was above the 95th percentile increased from 16% to 27% (p<.0001). The
findings seem to indicate that a higher relative weight is inversely correlated with an onset of
early menarche, after controlling for age and race.
Rosenfield, Lipton, & Drum (2009) took the data from the NHANES III (1988-1994) for
children aged 8 through 18 years of age. Data was taken from the NHANES III survey of the US
population from 1988 to 1994 of children aged 8 through 18 years old. Pubertal stages were
estimated at 5%, 50%, and 95% of attainment. They found that girls with excessive BMI showed
significantly higher breast appearance prevalence from ages 8.0 to 9.6 years (OR: 3.86 and 2.02,
respectively) and pubarche from ages 8.0 through 10.2 years old (OR: 4.50 and 1.87,
respectively) than the control group.
Environmental Toxins. Environmental toxins are thought to be factors in the
development of early/precocious puberty. The Federal Drug Administration (FDA) currently
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allows the use of six hormones in the food supply including many sex hormones: estradiol,
estriol, testosterone, and progesterone. Estrogen storage in fat tissue increases the risk of
overweight children. Additionally, parabens, a known toxin, are found in everyday household
items including soap, cosmetics, cleaning products, etc. The xenoestrogens mimic estrogen in the
body (Landa, 2012).
Buttke, Sircar, & Martin (2012) studied the association between the exposure of
endocrine-disrupting hormones (EDC) and the age of menarche for girls aged 12 to 16 years old.
They found that 2,5-dichlorophenol (2,5-DCP) alone and in combination with 2,4dichlorophenol (2,4 DCP) act as potential EDC’s and were inversely associated with an earlier
age of menarche (hazard ratios of 1.10; 95% CI: 1.01, 1.10 and 1.09; 95% CI 1.01, 1.19,
respectively; P=0.025). The phenol 2,5-DCP is a fumigant that is found in common household
items such as mothballs, insect repellants, deodorizers, and toilet disinfectants.
Boas et al. (2010) looked at urinary concentrations of twelve phthalate metabolites in
relation to serum levels of TSH, thyroid hormones, and IGF-1 in children ages 4 through 9 years
old. All associations in girls between peripheral thyroid hormones and unadjusted phthalate
metabolites were negative, reaching significance for total T3 with most phthalate metabolites, for
free T3 with MEP (monoethyl phthalate) and DEHP, di (2-ethylhexyl) metabolites, and for total
T4 with MEP (B=-5.19, p=0.013) and total phthalate score (B=-0.48, p=0.037). IGFBP-3
showed a significantly negative association with DEHP and MCiOP (monooxoisononyl
phthalate) metabolites (p<0.05). The results seem to indicate negative associations between
urinary phthalate concentrations and thyroid hormones, IGF-I (insulin-like growth factor I), and
growth in children.
Lopez-Espinosa, Mondal, Armstrong, Bloom, & Fletcher (2012) looked at the

Early and Precocious Puberty

9

relationship between thyroid function and Perfluoroalkyl acids in children who lived in close
proximity to a chemical plant (Teflon) and consumed contaminated drinking water.
Perfluoroalkyl acids (PFAAs), including perfluorooactanoate (PFOA, also called C8),
perfluorooctane sulfonate (PFOS), and perfluorononanoic acid (PFNA) were examined by serum
concentrations from 2005 through 2006 in 10, 725 children ages 1-17 years of age. The results
seem to indicate that serum measurements of PFOA concentrations are associated with thyroid
disease (usually hypothyroidism); odds ratio for hypothyroidism was 1.54 [95% confidence
interval (CI): 1.00, 2.37] and interquartile range (IQR) contrast of 13 to 68 ng/mL.
In a study of lab mice, Markay, Luque, Munoz de Toro, Sonnenschein, & Soto (2001)
examined the relationship between in utero exposure to low doses of bisphenol A (BPA) at 25
and 250 μg/kg. Their mammary glands were assessed for signs of breast enlargement at 10 days,
1 month, and 6 months of age. At 6 months of age the results of ductal and alveolar structures
were significantly higher in both classes of BPA exposed mice compared to the control group.
The mammary glands exhibited a 29% (P<0.01) and a 25% (P<0.05) breast enlargement in the
ductal area; a 237% (P<0.05) and a 219% (P<0.05) increase in the terminal duct area; a 192%
(P<0.05) and a 139% increase in the terminal end buds; and a 288% (P<0.01) and a 361%
(P<0.01) increase in the alveolar buds area. The results from this study seem to indicate that
lower than currently considered significant doses of BPA may lead to early breast enlargement,
usually the first sign of puberty.
Nutrition. Talpade (2008) looked at the relationship between nutritional intake and body
imaging on sexual maturation differences between 7 and 10 year old Hispanic American (HA)
and African American (AA) girls. The results indicated that AA girls with secondary sexual
characteristics consumed a diet higher in lipids (p=.025) and saturated fats (p=.048).
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Additionally, food consumption and race between the girls who experienced early sexual
maturation (one minimum characteristic) found significant differences between the consumption
of lipids (p=.04) being higher among AA and calcium (p=.04) being higher among HA. Higher
intakes of calcium among HA girls (p=.006) and lipids among AA girls (p=.049) showed
significant associations with increased breast development.
Vitamin Deficiency. Villamor, Martin, & Mora-Plazas (2011) followed 242 girls whose
mean age was 8.8 ± 1.6 years for 2.5 years and studied their Vitamin D nutrition in relation to
the timing of menarche. The results indicated that Vitamin D-deficient girls were 3.03 times
more likely to reach menarche earlier than vitamin D-sufficient girls (95% CI: 1.58-5.83). After
adjustments for age at baseline for BMI-for-age z-score (HR: 2.05, 95%CI: 1.03-4.07), the
relationship was partially attenuated.
Impact of Early/Precocious Puberty
Endocrine. Midyett, Moore, & Jacobson (2003) studied precocious puberty in girls
before age 8 years. Within the group, 12.3% of the patients ranging in age from 6 to 8 had
pathologic processes related to their precocious puberty, such as insulin
resistance/hyperinsulinemia, hypothyroidism, growth hormone deficiency, and congenital
adrenal hyperplasia. Approximately 45% of the study population was obese and 81% had
additional endocrine pathologies. Girls who exhibited two signs of puberty had the greatest
percentage of obesity compared to those with only one sign of puberty (P=.024); more than two
thirds of the girls who presented with two or more signs of puberty displayed a bone age >3SD
above the mean, indicating a risk for decreased final adult height. Girls with breast development
as the only sign of puberty exhibited the same amount of risk to losing adult height as the girls
who presented with two signs of puberty. The results seem to indicate that girls under 8 years of
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age who present with two signs of precocious puberty should receive a referral to an
endocrinologist and those with one sign of puberty should receive, at a minimum, a bone age
assessment.
Cardiovascular. Güven, Cinaz, & Bideci (2005) examined the relationship between
premature adrenarche (PA) and artherogenesis (artherogenic index, AI) in girls (ages 5.4 to 8.6
years old) with premature adrenarche. The bone age with PA positively correlated with AI
(P<0.05). Higher bone ages (P<0.05), weight, body mass index (BMI), systolic, diastolic, and
mean arterial blood pressures (MBP) were found in the girls with premature adrenarche
compared to their age matched counterparts. Additionally, the mean total cholesterol (TC), lowdensity lipoprotein-cholesterol (LDL-C), very low-density lipoprotein-cholesterol (VLDL-C),
TC/high-density lipoprotein-cholesterol (P=0.011) and LDL-C/HDL-C ratio (P<0.05), and
artherogenic index (P<0.05) were significantly higher in the premature adrenarche group. The
results seem to indicate a correlation between premature adrenarche and increased cholesterol
levels.
Psychological. Precocious puberty can have profound effects on an adolescent’s
psychological well-being. Liao, Missenden, Hallam, & Conway (2005) conducted a retrospective
qualitative study of women ages 31 to 65 years who underwent puberty before the age of 7 years
old and found two recurring themes: “on being different” (sub themed into “feeling different”,
“feeling a freak”, and “remaining different”) and “the adult child” (sub themed into loss of
childhood, blurring of boundaries between adult/child, and the sexual child). The adults reported
feeling different based on how people treated them. They reported feeling like freaks because
providers did not know how to stop their pubertal progression. They felt they remained different
even when their peers started puberty because they knew they had started it earlier. On being the
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adult child, the adults felt like they were treated like adults while they still retained the cognitive
abilities of a child, thereby being robbed of a childhood. The blurring of adult/child boundaries
was felt because “…other children are getting cuddled and talked about, and you feel like you’re
not because you look older, but you’re not, you’re really young, the same as them.” The sexual
child was described by one participant who recalled her mother had decided she had breast
development due to fondling herself; whereas another participant was told by doctors that her
early development was due to sexual abuse (there was none) which decreased her willingness to
talk to health professionals
Deardorff, Gonzales, Christopher, Roosa, & Millsap (2005) conducted a retrospective
study of women ages 18 to 22 years who were from four major ethnic groups (non-Hispanic
white, black, Latino, and Native American) and who experienced a pregnancy in their teens or
early 20s. The study examined the relationship between the participant’s onset of first menarche,
first sexual encounter, first alcohol use, and the age at first pregnancy. The participants sampled
experienced menarche earlier than 11.94 years (with early menarche being defined as before age
12). The earlier age of menarche correlated to earlier age at first alcohol use (β=.16; z=4.63), the
age at first alcohol use directly and positively related to age at first sex (β=.40; z=11.14) which
had a significant increase of earlier age at first pregnancy (β=.56; z=17.59). A second analysis
showed that all paths were significant (at P<.001) for the following: menarche to alcohol use
(β=.13; z=3.79); menarche to sex (β=.20; z=6.02); alcohol use to sex (β=.33; z=10.09); sex to
pregnancy (β=.46; z=14.46). The results seem to indicate that early menarche has a direct
correlation on early first sexual encounter, early alcohol use, and an increased risk of early
pregnancy.
Copeland, Shanahan, Miller, Costello, Angold, & Maughan (2010) studied the outcomes
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of early puberty in females. The longitudinal study consisted of girls ages 9, 11, and 13 years old
followed into adulthood. Their results showed that participants who reported early pubertal
development also reported increased criminal problems (P=0.34), early sexual activities
(P=0.11), and increased social (P=0.04) and psychiatric problems (P=0.04) during their
adolescent years. The largest areas of concern were in substance abuse and conduct problems
(odds ratios >3.0). These negative behaviors tapered off in adulthood and the girls reached the
same level of negative behaviors as their on-time or late puberty peers.
Deng, Tao, Wan, Hao, Su, & Cao (2011) studied young Chinese women in high school
(grades 7, 8, 10, and 11) and college students (freshman and sophomore) who reported early, ontime, and late onset of menarche. The results indicated increased psychopathologic emotional
symptoms, behavioral symptoms (p=0.000), and social adaptation problems (p=0.001) for high
school girls who reported early menarche (p=0.024). Additionally, the female college students
exhibited decreased psychopathology symptoms as follows: emotional symptoms (p=0.006),
behavioral symptoms (p=0.003), and social adaptation problems (p=0.000). The results indicated
higher frequency of disorders, such as psychopathological, suicide, and self-harming appeared in
the high school students who reported earlier menarche.
Kim & Lee (2012) evaluated the patterns of behavior and social competency in 34 girls
with precocious puberty. Height, body weight, BMI, and pubertal development were evaluated
along with a child behavior questionnaire that was completed by the parents. Weight (p<0.001)
and BMI (p=0.001), social competence (p=0.048), externalizing problems (p=0.029), total
behavior problems (p=0.008), thought problems (0.010), and attention problems (0.047) were
significantly higher in the precocious puberty group. The results seem to indicate a correlation
between increased weight and early puberty increasing the risk of behavior and social problems.
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Management Options For Gonadotropin-dependent Precocious Puberty
Children with precocious puberty have increased estrogen levels, which produce initial
early skeletal maturation and early epiphyseal plate closure that results in a decreased final adult
height. Affected children will have an increased height in early childhood sooner than their on
time/late puberty counterparts but will also stop skeletal maturation sooner. Oerter, Manasco,
Barnes, Jones, Hill, & Cutler (1991) conducted a study of children diagnosed with precocious
puberty who were medicated with deslorelin, a long-acting luteinizing hormone-releasing
hormone (LHRH) agonist that was used in LHRH-dependent precocious puberty to examine its
effectiveness in increasing final adult height among the participants. The National Institutes of
Health initiated the treatment in 1979; the following results are from the first forty-four patients
to have attained adult height from the long-term trial. LHRH decreases gonadotropin and sex
steroid levels leading to increased final adult height. At the start of treatment, the children were
7.1 ± 1.2 years old, had a mean delay of 3.1 ± 0.3 years between pubertal onset and treatment,
and a mean bone age of 11.8 ± 1.5 years. The study group received daily injections of deslorelin
for at least 4.1 ± 1.3 years, and had been discontinued from treatment for 2.4 years at the time of
study. The final adult height averaged -1.1 SD compared to the normal populations adult height.
The final adult height of the participants was significantly greater (-1.1 vs. -2.0 SD, P<0.01) than
the pretreatment height, but also significantly less than the predicted height at end of treatment (1.1 vs. -0.5 SD, P<0.01) and the genetic height derived from the parent’s measurements (-1.1 vs.
0.1 SD, P<0.01). The mean adult height for the girls was 157.0 ± 5.9 cm (-1.1 ± 1.0 SD). The
mean proximate adult height was significantly greater than the mean pretreatment predicted
height (-1.1 ± 1.3 SD vs. -2.0 ± 1.3 SD, P<0.01), by 5.2 ± 8.4 cm for the girls. The most recent
predicted height was less than the predicted height at the end of treatment by 2.2 ± 4.0 cm
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(P<0.01). Proximate adult height inversely correlated with pretreatment bone age (r=-0.35,
P=0.02). Additionally, basal luteinizing hormone levels (P<0.01), LHRH-stimulated LH levels
(P<0.01), LHRH-stimulated FSH levels (P<0.01), and Estradiol levels (P<0.01) all showed
decreased serum concentrations at the completion of treatment compared with pretreatment
values. The results seem to indicate that while deslorelin decreased hormone levels and increased
the pretreatment predicted height in the test subjects by an average of 5 cm, it did not restore
them to their full genetic potential.
Kauli, Galatzer, Kornreich, Lazar, Pertzelan, & Laron (1997) studied girls with central
precocious puberty (CPP) to determine the benefit of medication therapy on final height (FHt)
and target height (THt). Of the total population, 28 were untreated, 26 were treated with
cyproterone acetate (CyA), and 48 were treated with GnRH analogue (GnRHA). Their height
was compared to their respective target height. The results indicated that girls who received
treatment with either medication reached THt above (CyA group: FHt 157.8 +/- 5.1, THt 156.8
+/- 5.1cm; GnRHA group: 159.6 +/- 6.3, THt 157.7 +/- 5.7 cm) their non-treated counterparts
(THt +/- 0.5 SD; FHt 160.2 +/- 7.1, THt 159.5 +/- 6.6cm).
Conclusion
Early and precocious puberty is an increasingly global problem. Research has been done
in many areas showing correlations with overweight/obesity, nutritional/vitamin factors,
environmental chemicals/toxins, to name just a few. Identifying the cause of early puberty is
essential in preventing adverse psychosocial and health outcomes. Children with early and
precocious puberty have an increased risk of short stature, endocrine disorders (diabetes),
cardiovascular disease, behavioral problems, sexual abuse, increased alcohol abuse, increased
risk of early sexual encounter (which increase risk of STDs and cervical cancer), and increased
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risk of teenage pregnancy (increasing risk of low socioeconomic status).
Diagnostic testing should be performed on girls who are less than 8 years old presenting
with signs of puberty, or girls between 8 and 10 years old who are exhibiting pubertal
development and have any of the following: rapid progression of puberty with a skeletal
maturation bone age >2SD years ahead of their chronological age (diagnosed by x-ray of the
wrist) with a predicted height >2SD (4 inches) below their genetic target height, central nervous
system problems (seizures, hydrocephalus, etc.), or behavior problems associated with early
physical maturation. Diagnostic testing includes differentiating between central and peripheral
puberty. The provider should perform a thorough medical history and physical exam, order blood
tests (thyroid profile, Vitamin D levels, hormone levels: LH, FSH, Estradiol), x-ray of hand (to
determine bone age), and a GnRH stimulation test with blood sample (with central precocious
puberty then the other hormone levels will rise, with peripheral precocious puberty the other
hormone levels will remain the same). Tumors can be detected by a CT/MRI of the head and
abdomen. Cysts can be detected by ultrasound. If a cause is identified then treating the
cause/referral is the preferred method of choice. If bone scans indicate advanced bone age or the
child exhibits decreased coping skills with the maturation, referral to a pediatric endocrinologist
for further testing and treatment provides advanced care and possible relief of symptoms (Mayo
Clinic, 2013).
Treatment of precocious puberty can include treating the underlying disease if any is
found, psychological therapy, and medication to delay further pubertal onset. The complications
of precocious puberty can include psychological problems, short height, and increased risk of
cardiovascular disease (Mayo Clinic, 2013). The goal is to delay the onset of early puberty. This
gives the child time to reach psychological maturing, decreases the risk of short height, and helps
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decrease the risk of endocrine disorders (diabetes, PCOS) and cardiovascular disease.
With the knowledge gained from research, the healthcare provider can increase his or her
screening process by effectively evaluating, diagnosing, and hopefully preventing early or
precocious puberty. Modifiable factors include encouraging parents to buy products without
parabens, decrease stress in the home, eat a well balanced and nutritious diet, maintain a healthy
weight, monitor/decrease risk of sexual abuse, avoid toxins that mimic estrogens, and encourage
mothers to maintain a healthy weight during pregnancy to help prevent the risk of early or
precocious puberty. Universities, healthcare centers, drug companies, the Federal Drug
Administration, and the Environmental Protection Agency need to continue to expand and clarify
their research. As early and precocious puberty looks to be a multifactorial problem, additional
areas of research need to be completed to understand what else can increase the risk of early
pubertal timing. With research findings politicians can then enact statutes and laws to protect
young girls from potential hazards in food, household products, etc.
Additional studies need to be conducted to determine more causes of precocious puberty.
The earlier a cause is identified the earlier prevention and treatment can be implemented by
patients and providers to halt early pubertal timing and decrease its complications. To date, while
Canada and other countries have stopped using BPA in their products (a potential endocrine
disruptor), thus limiting the American consumers exposure, the FDA has yet to ban it from the
US market. The FDA needs to remove BPA and other known toxins from US products.
In conclusion, the American Academy of Pediatrics and other pediatric and medical
associations need more concise definitions and parameters implemented. Depending on what
article is referenced, the age for early and precocious puberty can be evaluated at less than 6, 8,
or 12 years. Also, agencies and physicians debate about the treatment options of precocious
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puberty. While some providers may see precocious puberty as a benign condition, others believe
the condition warrants further testing to make sure the early onset is not due to an endocrine
disorder, tumor, or disease process. More stringent evaluating, diagnosing and managing
guidelines from evidenced based practice would allow for better long term outcomes in young
girls.
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Author & Year
Tremblay & Frigon. (2005).
Precocious puberty in adolescent
girls: A biomarker of later
psychosocial adjustment
problems. Child Psychiatry and
Human Development, 36(1), 7394. Doi:10.1007/s1057800403489-2

Inclusion Criteria
Parents of 1039 girls completed a
questionnaire about theirs & the
family’s characteristics. Followed
children from 6 years old (nonpuberty) until 17 years of age.

Type of Study/Treatment
Representative sample of 3017
children & their parents.
Followed longitudinally from
1986 (children 6 years old) until
they were 17 years old.
Completed questionnaire yearly
evaluating anxiety, stress and
pubertal development.
Level 3

Davison, Susman, & Birch.
(2003). Percent body fat at age 5
predicts earlier pubertal
development among girls at age
9. Pediatrics, 111(4), 815-821.

181 girls age 5, 7, & 9 years old
with puberty being assessed at 9
years.

Longitudinal correlational study
examining relationship between
nutrition, weight, BMI, and waist
measurement on pubertal timing.
Level 4

Primary Outcomes /Conclusions
The results indicated that girls
who reported more anxiety at 8
years old had an increased risk of
early menses. Stress was
measured two ways the first was
the Family Adversity Index,
which evaluated socioeconomic
status, family structure, and
parental occupation, with a
distribution range from 0.00
(favorable condition) to 1.00
(higher level of adverse
conditions); M=0.23, SD=0.23,
and M=0.24, SD=0.24 at 6 and 8
years old, respectively). Next, the
Stressful Event Checklist, which
attributed a 1-point score with a 0
to 5 distribution range for
divorce, separation, and disease
of the child within the last 12
months that was assessed
between 6 and 7 and between 7
and 8 years old; M=0.51,
SD=0.84). Consequently, the
girls who entered puberty earlier
than their peers reported less
sleep, more externalized problem
behaviors, and increased
difficulty relating to their parents
and peers.
Girls at 5 years of age who had a
higher percent body fat; and girls
who were 7 years old with a
higher percent body fat, greater
linear increase in percent body fat
(OR=1.17; 95% CI=1.05-1.30),
higher percentile BMI, larger
waist circumference, or greater
linear increase in weight
circumference (OR=1.12; 95%
CI=1.01-1.24) were more at risk
of undergoing earlier sexual
development at 9 years. The girls
with earlier puberty exhibited
higher estradiol levels.
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Author & Year
Boynton-Jarrett, Rich-Edwards,
Fredman, Hilbert, Michels,
Forman, & Wright. (2011).
Gestational weight gain and
daughter’s age at menarche.
Journal of Women’s Health,
20(8), 1193-1200.
Doi:10.1089/jwh.2010.2517

Inclusion Criteria
32,218 mother/daughter dyads

Type of Study/Treatment
Prospective cohort study of
mother/daughter dyads looking
@ mothers gestational weight
gain & daughter’s age of
menarche.
Level 4

Anderson, Dallal, & Must.
(2003). Relative weight and race
influence average age at
menarche: Results from two
nationally representative surveys
of US girls studied 25 years
apart. Pediatrics, 111(4), 844850.

1109 girls ages 10+years and
2218 girls ages 12-15 years old.

National Health Examination
Surveys cycles II & III (19631970) compared with results from
Third National Health and
Nutrition Examination Survey
(1988-1994) evaluating weight,
BMI and age of menarche.
Systematic review of
correlational studies.
Level 4

Rosenfield, Lipton, & Drum.
(2009). Thelarche, pubarche, and
menarche attainment in children
with normal and elevated body
mass index. Pediatrics, 123(1),
84-88. Doi:10.1542/peds.20080146

Children from the Third National
Health and Nutrition
Examination Survey and the
NHANES III survey of the US
population from 1988 to 1994 of
children aged 8- through 18 years
old. The data was extrapolated
from girls with a normal BMI
(control group) and those with
excessive BMI (≥ 85th
percentile). Pubertal stages were
estimated at 5%, 50%, and 95%
of attainment.

Survey Sampling Design.
Single observational study
evaluating the relationship
between BMI and pubertal
development.
Level 4

Primary Outcomes/Conclusions
Mothers who had a Gestational
Weight Gain (GWG) of <10 lbs.
or >40 lbs. were 30% more likely
to have daughters with early
onset menarche based on an
adjusted logistic regression
models (OR=1.31, 95% CI=1.051.62, and OR=1.27, 95%
CI=1.06-1.56; P=0.0059).
The results indicated that the
average age of menarche dropped
approximately 2 ½ months on
average, from 12.75 to 12.54
years (NHES 95% CI: 12.6912.82 years compared to
NHANES III 95% CI: 12.4412.64 years), and the percentage
of girls aged 10 to 15 years old
were above the 95th percentile for
BMI increased from 16% to 27%
(BMI z-score 0.93 units higher in
NHES and 0.83 units higher;
p<.0001 in independent sample t
test in NHANES IIII than girls
who had not reached menarche)
over the 25 year time period. The
higher relative weight was
associated with the increased
onset of early menarche, after
controlling for age and race.
The results concluded that girls
with excessive BMI showed
significantly higher breast
appearance prevalence from ages
8.0 to 9.6 years (OR: 3.86 and
2.02, respectively) and pubarche
from ages 8.0 through 10.2 years
old (OR: 4.50 and 1.87,
respectively) than the control
group

Early and Precocious Puberty

21

Author & Year
Buttke, Sircar, & Martin. (2012).
Exposures to endocrine-disrupting
chemicals and age of menarche in
adolescent girls in NHANES
(2003-2008). Environmental
Health Perspectives, 120(11),
1613-1618.

Inclusion Criteria
440 females age 12-16 years old

Type of Study/Treatment
(NHANES) Cross-sectional,
multistage, stratified, cluster
sampling survey conducted by
the CDC looking at the
relationship between potential
EDC’s and menarche in females.
Level 2

Boas, Frederiksen, FeldtRasmussen, Skakkebaek,
Hegedüs, Hilsted, Juul, & Main.
(2010). Childhood exposure to
phthalates: Associations with
thyroid function, insulin-like
growth factor I, and growth.
Environmental Health
Perspectives, 118(10), 14581464. Doi:10.1289.ehp.0901331

845 children 4-9 years of age.
Urinary concentrations of 12
phthalate metabolites & serum
levels of TSH, thyroid hormones,
& IGF-I.
Exclusions were children who
suffered from diseases prone to
affect growth or endocrine status
as well as children with clinical
signs of puberty.

Children who had previously
participated in a longitudinal
cohort study, for which their
mothers (1,953) during
pregnancy were consecutively
enrolled. Study looked at urine
phthalate concentrations and the
hormone levels in children.
Cohort study.
Level 4

Lopez-Espinosa, Mondal,
Armstrong, Bloom, & Fletcher.
(2012). Thyroid function and
perfluoroakyl acids in children
living near a chemical plant.
Environmental Health
perspectives, 120(7), 1036-1041.

10,725 children between 1-17
years old that lived near Teflon
chemical plant and had
consumed local water for at least
one year before 2004

Convenience sampling of the
population that met the inclusion
criteria. Looked at the
relationship between PFOA’s and
thyroid disease.
Level 4

Primary Outcomes/Conclusions
2,5-DCP, a potential EDC, was
inversely associated with the age
of menarche in females (hazard
ratios 1.10; CI 95%=1.01, 1.19,
P=0.025). This is a fumigant that
is also found in mothballs, insect
repellants, deodorizers, and toilet
disinfectants.
The results indicated negative
associations between urinary
phthalate concentrations and
thyroid hormones, IGF-1, and
growth in children. All
association in girls between
peripheral thyroid hormones and
unadjusted phthalate metabolites
were negative, reaching
significance for total T3 with
most phthalate metabolites, for
free T3 with MEP and DEHP
metabolites, and for total T4 with
MEP (B=-5.19, p=0.013) and
total phthalate score (B=-0.48,
p=0.037). IGFBP-3 was
significantly negatively
associated wit DEHP metabolites
and MCiOP (p<0.05).
The study found that serum
measurements of PFOA
concentrations were positively
associated with thyroid disease
(usually hypothyroidism); odds
ratio for hypothyroidism (n=39)
was 1.54 [95% confidence
interval (CI): 1.00, 2.37] for and
interquartile range (IQR) contrast
of 13 to 68 ng/mL
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Author & Year
Markey, Luque, Munoz de Toro,
Sonnenschein, & Soto,. (2001). In
utero exposure to bisphenal a
alters the development and tissue
organization of the mouse
mammary gland. Biology of
Reproduction, 65(2001), 12151223.

Inclusion Criteria
Sexually mature, female CD-1
mice (8 weeks of age).

Type of Study/Treatment
Clinical trial with control group.
Single nonrandomized trial. Lab
mice exposed to BPA in utero
and then evaluated at different
intervals for breast enlargement
after birth.
Level 2

Talpade, M. (2008). Hispanic
versus African American girls:
Body image, nutrition, and
puberty. Adolescence, 43(169),
119-127.

23 Hispanic Americans & 44
African American girls ages 7-10
years in pre-pubertal & early
pubertal stages

Pilot study. Convenience sample.
The study looked at the
relationship between nutrition
and Hispanic and African
American girl’s pubertal timing.
Level 4

Villamor, E., Martin, C., & MoraPlazas, M. (2011). Vitamin d
deficiency and age at menarche:
A prospective study. American
Journal of Clinical Nutrition,
94:1020-1025.

242 girls from the Bogota School
Children Cohort. Ages ranged
from 8.8 to +/- 1.6 years

Prospective Study. Cohort. The
study examined the relationship
between Vitamin-D deficient and
Vitamin-D sufficient girl’s and
the timing of pubertal
development.
Level 4

Primary Outcomes/Conclusions
The researchers examined the
relationship between in utero
exposure to low doses of
bisphenol A (BPA) at 25 and 250
μg/kg of body and the amount of
breast enlargement were assessed
at 10 days, 1 month, and 6
months of age. At 6 months of
age the results of ductal and
alveolar structures related to the
control group were significant in
both classes of BPA exposure.
The mammary glands exhibited a
29% (P<0.01) and a 25%
(P<0.05) increase, respectively,
in the ductal area; a 237%
(P<0.05) and a 219% (P<0.05)
increase in the terminal duct area;
a 192% (P<0.05) and a 139%
increase, respectively, in the
terminal end buds; and a 288%
(P<0.01) and a 361% (P<0.01)
increase, respectively, in the
alveolar buds area. Researchers
considered the results significant
at P<0.05. Even at lower than
significant doses of BPA can lead
to early breast enlargement, ,
which can also increase the risk
of breast cancer throughout a
females life.
The results indicated that AA
girls with secondary sexual
characteristics consumed higher
intakes of Lipids,
𝑥 2(3,N=54)=9.337, p=.025 and
saturated fats 𝑥 2(3),
N=54)=7.918, p=.048;
additionally, the Mann-Whitney
U test looked at food
consumption and race between
the girls who experienced early
sexual maturation and found the
consumption of lipids U
(n=28)=36, p=.04; and calcium,
U (n=28)=36, p=.04; among HA
(n=7) versus AA girls (n-21) who
presented with the presence of
one sexual secondary
characteristic. Finally, there was
a significantly high intake of
calcium among HA girls that
associated with breast
development, Mann Whitney
U=12, n=6, p=.006 Mean
Rank=18 for HA and Mean
Rank=9) and a high intake of
Lipids among AA girls, Mann
Whitney U=21, n=16, p=.049
(Mean Rank=1 for HA and Mean
Rank=13).
Vitamin D-deficient girls were
3.03 (95% CI: 1.58-5.83) times
more likely to reach menarche
than vitamin D-sufficient girls.
After adjustments for age at
baseline for BMI-for-age z-score
(HR: 2.05, 95%CI: 1.03-4.07)
revealed attenuated results.
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Author & Year
Midyett,J., Moore, W., &
Jacobson, J. (2003). Are pubertal
changes in girls before age 8
benign? Pediatrics, 111(1), 47-51.

Inclusion Criteria
1,570 girls referred for
precocious puberty s/sx

Type of Study/Treatment
Retrospective chart review by a
Pediatric Endocrinology clinic
looking at girls referred for
precocious puberty signs and
their exam findings.
Level 4

Kim, E., & Lee, M. (2012).
Psychosocial aspects in girls with
idiopathic precocious puberty.
Psychiatric Investigation, 9(1),
25-28.
Doi:10.4306/pi.2012.9.1.25

34 girls diagnosed with
idiopathic precocious puberty
who were patients in the
Department of Pediatrics,
Chosun University hospital from
June 2010 to August 2010.
Compared to 39 first year female
studants in elementary school in
Gwang-san gu with no evidence
of pubertal development.

Clinical group comparison study.
Convenience sample. Examined
the relationship between weight
and BMI on pubertal timing as
well as the resulting psychosocial
problems.
Level 4

Güven, A., Cinaz, P., & Bidecii,
A. (2005). Is premature
adrenarche a risk factor for
atherogenesis? Pediatric
International, 47:20-25.

24 prepubertal girls (age range,
5.4-8.6 years) with 13 age
matched controls (5.7-8.5 years).

Cohort study. Study examined
the relationship between Lipid
values and premature adrenarche.
Level 4

Liao, L., Missenden, K., Hallam,
R., & Conway, G. (2005).
Experience of early pubertal
development: A preliminary
analysis. Journal Of Reproductive
and Infant Psychology, 23(3),
219-233.
Doi.10.1080/02646830500165804

5 participants ages 31-65 years.
Retrospective study. All had
experienced pubertal
development before 7 years old.

Retrospective Single Qualitative
study. Examined the subjective
feelings/experiences of women
who reported early/precocious
puberty.
Level 4

Primary Outcomes/Conclusions
Girls with two signs of puberty
(thelarche, pubarche, or
menarche) had greater obesity
than those with one sign (p=0.24)
& displayed a bone age >3SD
above the mean. Girls with only
breast development had the same
risk to lose adult height as those
with 2 signs of puberty.
The results indicated that weight
(p<0.001) and BMI (p=0.001)
were significantly higher in the
precocious puberty group.
Additionally, social competence
(p=0.048), externalizing
problems (p=0.029), total
behavior problems (p=0.008),
thought problems (0.010), and
attention problems (0.047) were
significantly higher in the
precocious puberty group. The
study shows a correlation
between that weight impact
puberty, and that early puberty
increases behavior problems and
social competencies.
Findings included TC/HDL-C
(rho, -0.54; P, 0.011) and LDLC/HDL-C (rho, -0.0; P<0.05) and
artherogenic index (AI; rho, 0.43; P<0.05). Finally, the bone
age with PA positively correlated
with AI (rho, 0.456; P<0.05) The
findings indicate higher bone
age, weight, body mass index
(BMI), systolic, diastolic, and
mean arterial blood pressure
(MBP) in the girls with
premature adrenarche.
Additionally, the mean total
cholesterol (TC), low-density
lipoprotein-cholesterol (LDL-C),
very low-density lipoproteincholesterol (VLDL-C), TC/highdensity lipoprotein-cholesterol
(HDL-C) and LDL-C/HDL-C
ratio, and artherogenic index
were significantly higher in the
premature adrenarche group as
well.
2 themes found:
“on-being different” & “the adult
child”
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Author & Year
Wise, L., Palmer, J., Rothman, E., &
Rosenberg, L. (2009). Childhood
abuse and early menarche: Findings
from the black women’s health
study. American Journal of Public
Health, 99(S2), S460-S466.

Inclusion Criteria
35,330 Black women

Type of Study/Treatment
Prospective cohort study.
Regression data. Studied the
relationship between
sexual/physical abuse and
pubertal timing.
Level 4

Deardorff, J., Gonzales, N.,
Christopher, F., Roosa, M., &
Millsap, R. (2005). Early puberty
and adolescent pregnancy: The
influence of alcohol use. Pediatrics,
116(6), 1451-1456.
Doi:10.1542/peds.2005-0542

666 women ages 18 to 22 years
who were either African
American (N-92), non-Hispanic
white (N=191), Latino
(N=209), or Native American
(159). Recruited at health
clinics, shelters, colleges, &
private providers).

Convenience sampling of
women who were in the target
age range & had experienced a
pregnancy in their teens or early
20’s.
Examined the relationship
between early pubertal timing
and alcohol abuse, first sexual
encounters, and pregnancy.
Level 4

Copeland, W., Shanahan, L., Miller,
B., Costello, J., Angold, A., &
Maughan, B. (2010). Outcomes of
early pubertal timing in young
women: A prospective populationbased study. The American Journal
of Psychiatry, 167:1218-1225.
Doi:10.1176/appl.ajp.2010.09081190

1,420 children ages 9, 11, & 13
followed into adulthood

Longitudinal study with 3
cohorts: ages 9, 11, & 13.
Examined the relationship
between early puberty and
behavioral problems.
Level 4

Primary Outcomes
After adjusted analyses, sexual
abuse was positively correlated
with early menarche, and
physical abuse had a weak but
statistically significant link with
early menarche. Women who
reported any abuse had 1.12
times the risk of early menarche
compared to those who reported
no abuse (95%CI=1.08, 1.16).
Physical abuse only were 1.05
times more likely for early
menarche (95%CI=1.01, 1.09),
and 1.27 for sexual abuse only
(95%CI=1.20, 1.35), and 1.22
for physical and sexual abuse
(95%CI=1.16, 1.28).
Additionally, the increased
number of sexual abuse
incidents of 1 to 3 (1.26,
95%CI=1.18, 1.34) and 4 or
more (1.34, 95%CI=1.23, 1.45)
increased the risk of early
menarche
Experienced menarche lower
than 11.94 years (with early
menarche being defined as
before age 12). Age at menarche
related to both age at first
alcohol use (β=.16; z=4.63). Age
at first alcohol use directly and
positively related to age at first
sex (β=.40; z=11.14), which had
a significant path to age at first
pregnancy (β=.56; z=17.59)
were also significant. The
squared multiple correlation for
age at first pregnancy (z=5.87)
was .32, an indicator of the
indirect effect between
menarche and pregnancy (6.62).
A second analysis showed that
all paths were significant (at
P<.001) for the following:
menarche to alcohol use (β=.13;
z=3.79); menarche to sex
(β=.20; z=6.02); alcohol use to
sex (β=.33; z=10.09).; sex to
pregnancy (β=.46; z=14.46).
Early puberty resulted in
criminal problems (P=0.34);
early sexual activities (P=0.11),
social problems (P=0.04); and
psychiatric problems (P=0.04)
during the adolescent years. The
biggest areas of concern were in
substance abuse and conduct
problems (odds ratios >3.0).
Negative behaviors tapered off
in adulthood and the girls
reached the same level of
negative behaviors as their ontime or late puberty mature
peers.
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Author & Year
Deng, F., Tao, F., Wan, Y., Hao, J.,
Su, P., & Cao, Y. (2011). Early
menarche and psychopathological
symptoms in young Chinese women.
Journal of Women’s Health, 20(2),
207-213.
Doi:10.1089/jwh.2010.2102

Inclusion Criteria
5,597 high school students
(grades 7, 8, & 11)& 2,768
college students (freshman &
sophomore).

Type of Study/Treatment
Stratified cluster sampling.
Cohort study. Examined the
relationship between early
pubertal timing and
psychopathological symptoms.
Level 4

Oerter, K., Manasco, P., Barnes, K.,
Jones, J., Hill, S., & Cutler, G.
(1991). Adult height in precocious
puberty after long-term treatment
with deslorelin. Journal of Clinical
Endocrinology and Metabolism,
73(6), 1235-1240.

44 children (38 girls and 6
boys) out of 161 who were the
first to reach adult height in a
long-term trial of deslorelin.
Diagnosis of (Luteinizing
hormone-releasing hormone)
LNRH-dependent precocious
puberty (as determined by
response to LNRH)

Longitudinal clinical trial study.
Single non-randomized trial.
Examined the relationship
between early/precocious
children’s predicted height and
their final height after taking
Deslorelin.
Level 2

Primary Outcomes/Conclusions
The MSQA indicated
psychopathology in emotional
symptoms were 20.6%, 15.7%,
and 16.9%, respectively, for the
early, on-time, and late
menarche groups (p=0.024); the
percentages in behavioral
symptoms were 27.7%, 19.3%,
and 19.3%, respectively
(p=0.000); the percentages in
social adaptation problems were
18.2%, 12.0%, and 12.7%
respectively (p=0.001). For
college students, the percentages
of psychopathology in emotional
symptoms were 17.3%, 9.4%,
and 12.5%, respectively, for the
early, on-time, and late
menarche groups (p=0.006); the
percentages in behavioral
symptoms were 18.2%, 9.8%,
and 13.3%, respectively
(p=0.003); the percentage in
social adaptation problems were
17.3%, 6.8%, and 7.0%,
respectively (p=0.000).
At the start of treatment, the
children had a mean bone age of
11.8 ± 1.5 years prior to starting
treatment. The mean adult height
for the girls was 157.0 ± 5.9 cm
(-1.1 ± 1.0 SD). The mean
proximate adult height was
significantly greater than the
mean pretreatment predicted
height (-1.1 ± 1.3 SD vs. -2.0 ±
1.3 SD, P<0.01), by 5.2 ± 8.4
cm for the girls. The most recent
predicted height was less than
the predicted height at the end of
treatment by 2.2 ± 4.0 cm
(P<0.01). Proximate adult height
inversely correlated with
pretreatment bone age (r=-0.35,
P=0.02). Basal luteinizing
hormone levels decreased from
8.7 ± 5.0 IU/L before the
treatment to 3.1 ± 1.5 IU/L at the
end of treatment (P<0.01). The
peak LHRH-stimulated LH
levels decreased from 76.3 ±
53.1 IU/L before treatment to
3.8 ± 2.3 IU/L at the end of
treatment (P<0.01). Peak
LHRH-stimulated FSH levels
decreased from 24.8 ± 16.8 IU/L
before treatment to 3.0 ± 1.5
IU/L at the end of treatment
(P<0.01). Estradiol levels in the
girls were 243.7 ± 229.0 pmol/L
before treatment and suppressed
to 58.7 ± 18.4 pmol/L by the end
of the treatment (P<0.01). After
discontinuation of the
medication, the mean ± SD
growth was 5.1 ± 3.2, (r=0.34,
P=0.025) and inversely with
bone age (r=-0.53, P=0.0002).
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Kauli, R., Galatzer, A., Kornreich,
L., Lazar, L., Pertzelan, A., & Laron,
Z. (1997). Final height of girls with
central precocious puberty, untreated
versus treated with cyproterone
acetate or GnRH analogue. A
comparative study with re-evaluation
of predictions by the Bayley-Pinneau
method. Hormone Res, 47(2), 54-61.

Inclusion Criteria
102 girls with central
precocious puberty.

26
Type of Study/Treatment
Cohort study. Of the 102
participants, 26 were treated
with Cyporterone Acetate
(CyA), 48 were treated with
GnRH analogue, and 28 were
untreated.
Examined the difference in final
female height between who
were treated with either CyA or
GnRH or untreated.
Level 2

Primary Outcomes/Conclusions
Their height was compared to
the respective target height.
Approximately half of the
untreated girls had a slow course
of puberty and reached THt +/0.5 SD (FHt 160.2 +/- 7.1, THt
159.5 +/- 6.6 cm); while the
other half had an accelerated
course of puberty with a FHt
well below THt (FHt 150.8 +/4.3, THt, 159.2 +/- 5.9 cm) and
most were below the height-SDS
of both parents. However, the
treated girls (both medications)
reached THt above (CyA group:
FHt 157.8 +/- 5.1, THt 156.8 +/5/1cm; GnRHA group: 159.6 +/6.3, THt 157.7 +/- 5.7 cm). The
results show that both that final
height (FHt) is increased with
either treatment (cytproterone or
GnRH) regimens. Additionally,
the optimal treatment should be
started in girls younger than 12
years due to a decreased bone
age.
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